Inhibition of serine proteases by steroids.
Proteolysis of 14C-labeled globin, as well as the hydrolysis of the specific substrate benzoyl tyrosine ethyl ester, by purified bovine chymotrypsin was found to be inhibited by several steroid hormones. The inhibition of chymotrypsin by the steroids was of a competitive nature, with Ki values of 9.9 x 10(-5) M for triamcinolone (9-fluoro-11 beta, 16 alpha, 17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione), 1.6 x 10(-4) M for cortisol (11 beta, 17 alpha, 21-trihydroxypregn-4-ene-3,20-dione), 3.7 x 10(-4) M for testosterone (17 beta-hydroxy-4-androsten-3-one), 5.0 x 10(-4) M for dexamethasone (9-fluoro-11 beta, 17,21-trihydroxy-16 alpha-methyl-1,4-pregnadiene-3,20-dione) and 1.0 x 10(-4) M for epicortisol (11 alpha, 17,21-trihydroxy-4-pregnene-3,20-dione). The activity of purified bovine trypsin on its specific substrate, TAME (tosyl arginine methyl ester), also showed a similar pattern of inhibition by steroids. Both chymotrypsin and trypsin were found to bind 3H-labeled dexamethasone and cortisol. This binding was markedly inhibited by the general protease inhibitor, PMSF (phenylmethanesulfonyl fluoride), whereas the chymotrypsin-specific inhibitor, TPCK (L-[1-tosyl-amido-2-phenyl]ethylchloromethyl ketone), inhibited only the steroid binding to chymotrypsin but not to trypsin. These observations indicate that serine proteases recognize steroid hormones in a fashion similar to the recognition of their specific substrates and that the steroids inhibit activity of these enzymes at their binding sites.
D000818:Animals; D002417:Cattle; D002918:Chymotrypsin / Q000378:metabolism; D004952:Esters / Q000378:metabolism; D005914:Globins / Q000378:metabolism; D006868:Hydrolysis; D007700:Kinetics; D011480:Protease Inhibitors / Q000494:pharmacology*; D011485:Protein Binding; D013256:Steroids / Q000494:pharmacology*; D014357:Trypsin / Q000378:metabolism
D004952:Esters; D011480:Protease Inhibitors; D013256:Steroids; D005914:Globins; D002918:Chymotrypsin; D014357:Trypsin